This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Care

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Risk of Subsequent Hypoglycemia is Low When Diabetes Treatment is Intensified

Posted: Saturday, June 30, 2007

Clinicians should not be afraid of intensifying treatment in diabetic patients with inadequately controlled glucose levels because the subsequent risk of developing hypoglycemia is quite low, a new study has shown.

Diabetes Reduces Life Expectancy by 8 Years

Posted: Friday, June 22, 2007

Before heart disease even develops among patients with heart disease, the effects on life expectancy have already begun, found researchers.

New Study Shows Chromium Improves Diabetes and Lipid Control

Posted: Friday, June 22, 2007

Published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).

Slow Release Topiramate Helps Diabetics Lose Weight

Posted: Friday, June 22, 2007

A controlled release formulation of topiramate is effective adjunctive therapy for weight loss in obese type 2 diabetics treated with diet and exercise alone or in combination with metformin, researchers report in the June issue of Diabetes Care.

New Study Shows No Increased Heart Risk With Avandia

Posted: Thursday, June 14, 2007

Findings from an interim analysis of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), shows further proof the safety of Avandia.

FDA Orders New Safety Labels for Rosiglitazone (Avandia) and Pioglitazone (Actos)

Posted: Thursday, June 14, 2007

The FDA Commissioner Andrew C. von Eschenbach, M.D., told a congressional hearing that the FDA will beef up the cardiovascular warnings on the labels of both rosiglitazone (Avandia) and pioglitazone (Actos).

Saliva A Marker for Type 2 Diabetes

Posted: Thursday, June 14, 2007

Saliva may be a marker for both periodontal disease activity and hyperglycemia in uncontrolled type 2 diabetes, according to new research.

Type 2 Diabetes Tied to Brain Atrophy in the Elderly

Posted: Thursday, June 14, 2007

Type 2 diabetes has a negative effect on brain tissue volumes and regional cerebral perfusion in elderly patients, according to researchers.

Once-Weekly Exenatide Formulation Improves Glycemic Control and Body Weight

Posted: Thursday, June 14, 2007

There were no serious adverse events related to exenatide use, the report indicates, and none of the mild to moderate adverse events required discontinuation of exenatide LAR.

How Tummy Surgery Cures Diabetes In A Matter of Days

Posted: Friday, June 08, 2007

Scientists at Swansea University School of Medicine have been funded to investigate why weight-reducing surgery can lead to the almost immediate disappearance of diabetes in patients even before any weight loss.